The store will not work correctly when cookies are disabled.
4-[(5-Methyl-3-phenylisoxazol-4-yl)methoxy]benzoic Acid
ID: ALA4522513
PubChem CID: 155543008
Max Phase: Preclinical
Molecular Formula: C18H15NO4
Molecular Weight: 309.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1onc(-c2ccccc2)c1COc1ccc(C(=O)O)cc1
Standard InChI: InChI=1S/C18H15NO4/c1-12-16(17(19-23-12)13-5-3-2-4-6-13)11-22-15-9-7-14(8-10-15)18(20)21/h2-10H,11H2,1H3,(H,20,21)
Standard InChI Key: MKCUSTFSCYUINE-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
28.9113 -11.3029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9052 -12.1242 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6841 -12.3844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1753 -11.7251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6940 -11.0586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9055 -10.2652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3237 -9.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5394 -8.8921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3331 -8.6806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9091 -9.2586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7023 -10.0527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9287 -13.1641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9925 -11.7311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3958 -12.4419 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.2130 -12.4479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6144 -13.1607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4308 -13.1671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8454 -12.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4377 -11.7489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6227 -11.7459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6626 -12.4670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0669 -13.1771 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.0755 -11.7618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
6 5 1 0
7 6 2 0
8 7 1 0
9 8 2 0
10 9 1 0
11 10 2 0
6 11 1 0
3 12 1 0
4 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
21 22 2 0
21 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 309.32 | Molecular Weight (Monoisotopic): 309.1001 | AlogP: 3.93 | #Rotatable Bonds: 5 |
Polar Surface Area: 72.56 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.36 | CX Basic pKa: 0.40 | CX LogP: 3.79 | CX LogD: 0.87 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.77 | Np Likeness Score: -0.99 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |